Literature DB >> 7237027

Severe complications from partial splenic embolization in patients with liver failure.

I Vujic, J W Lauver.   

Abstract

Transcatheter embolization of the spleen is gaining popularity as a non-surgical method of treatment for hypersplenism. While early reports documented frequent serious complications, a more recent study noted good results using a fractionated approach with only partial embolization of the periphery of the spleen. This technique was recently used on three patients with hypersplenism associated with severe liver disease. All had grave complications, including sepsis, pneumonia, abscess formation, and progressive liver failure, and all died within six weeks of the angiographic procedure in spite of good haematological responses. Since it is frequently this category of patient in whom the procedure is attempted, definitive surgical splenectomy is suggested following the embolization as soon as the clotting parameters return to normal.

Entities:  

Mesh:

Year:  1981        PMID: 7237027     DOI: 10.1259/0007-1285-54-642-492

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  16 in total

1.  Role of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia.

Authors:  Heba M Abdella; Amal T Abd-El-Moez; Mohammed E Abu El-Maaty; Ali Z Helmy
Journal:  Indian J Gastroenterol       Date:  2010-05-05

2.  Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenism.

Authors:  Masaki Kato; Naoya Shimohashi; Jiro Ouchi; Kisaku Yoshida; Yuichi Tanabe; Kenji Takenaka; Makoto Nakamuta
Journal:  J Gastroenterol       Date:  2005-11       Impact factor: 7.527

3.  Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia.

Authors:  Chi-Ming Lee; Ting-Kai Leung; Hung-Jung Wang; Wei-Hsing Lee; Li-Kuo Shen; Jean-Dean Liu; Chun-Chao Chang; Ya-Yen Chen
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

4.  Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications.

Authors:  Mingyue Cai; Wensou Huang; Chaoshuang Lin; Zhengran Li; Jiesheng Qian; Mingsheng Huang; Zhaolin Zeng; Jingjun Huang; Hong Shan; Kangshun Zhu
Journal:  Eur Radiol       Date:  2015-05-23       Impact factor: 5.315

5.  Evaluation of splenic embolization in patients with portal hypertension and hypersplenism.

Authors:  A Alwmark; S Bengmark; P Gullstrand; B Joelsson; A Lunderquist; T Owman
Journal:  Ann Surg       Date:  1982-11       Impact factor: 12.969

6.  Radiofrequency ablation for hypersplenism in patients with liver cirrhosis: a pilot study.

Authors:  Quanda Liu; Kuansheng Ma; Zhenping He; Jiahong Dong; Xin Hua; Xuequan Huang; Liang Qiao
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

7.  Partial splenic embolisation using n-butyl cyanoacrylate: intraprocedural evaluation by magnetic resonance imaging.

Authors:  Jun Koizumi; Chihiro Itou; Rick Wray; Kazunori Myojin; Takeshi Hashimoto; Yoshimi Nagata; Hiroshi Yamamuro; Tomoatsu Tsuji; Tamaki Ichikawa; Kouichi Shiraishi; Tatehiro Kagawa; Tetsuya Mine; Norihito Watanabe; Mitsunori Matsumae; Bertrand Janne d'Othée
Journal:  Eur Radiol       Date:  2012-11-19       Impact factor: 5.315

8.  Complications of partial splenic embolization in cirrhotic patients.

Authors:  Takahisa Sakai; Katsuya Shiraki; Hidekazu Inoue; Kazushi Sugimoto; Shigeru Ohmori; Kazumoto Murata; Koujiro Takase; Takeshi Nakano
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

9.  Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism.

Authors:  Tomohiko Akahoshi; Morimasa Tomikawa; Daisuke Korenaga; Koji Ikejiri; Motonori Saku; Kenji Takenaka
Journal:  Surg Endosc       Date:  2009-08-19       Impact factor: 4.584

10.  Pancreatic tissue damage by transcatheter arterial embolization for hepatoma.

Authors:  K N Khan; K Nakata; M Shima; Y Kusumoto; N Ishii; T Koji; S Nagataki
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.